2008年中国95本进入SCI杂志的期刊汇总

2008-09-30 MedSci原创 MedSci原创

至2008年止,中国共有147本杂志进入SCI (不包括SCIE,即SCI expanding)。 大部分是物理,化学的,部分是生物和医学的。下面将生物医学相关的标出来,便于查看。如果要查询全部的影响因子,可以在这里:http://www.medsci.cn/sciif.asp(2008年SCI影响因子智能查询系统,已包括全部的147种中国期刊),中国的147种详细见:中国全部147

至2008年止,中国共有147本杂志进入SCI (不包括SCIE,即SCI expanding)。
大部分是物理,化学的,部分是生物和医学的。下面将生物医学相关的标出来,便于查看。
如果要查询全部的影响因子,可以在这里:https://www.medsci.cn/sciif.asp (2008年SCI影响因子智能查询系统,已包括全部的147种中国期刊),中国的147种详细见:中国全部147种SCI杂志全目录
 
下方仅95本,不全!2007年以前为95种,2008年又增加收录38种,同时还有一部分台湾,香港的,合计147种。
 

期刊英文名称

期刊中文名称

ISSN

Total Cites
总被引频次

Impact Factor
影响因子

本学科类目

本学科收录期刊数量

影响因子排位

1

Acta Biochimica et Biophysica Sinica

生物化学与生物物理学报(英文版)

1672-9145

631

1.017

BIOCHEMISTRY & MOLECULAR BIOLOGY;
BIOPHYSICS

263
69

229
57

2

Acta Chimica Sinica

化学学报

0567-7351

2233

0.844

CHEMISTRY, MULTIDISCIPLINARY

127

76

3

Acta Geologica Sinica-English Edition

地质学报(英文版)

1000-9515

1216

1.781

GEOSCIENCES, MULTIDISCIPLINARY

137

40

4

Acta Mathematica Scientia

数学物理学报(英文版)

0252-9602

215

0.216

MATHEMATICS

207

195

5

Acta Mathematica Sinica-English Series

数学学报(新辑,英文版)

1439-8516

791

0.562

MATHEMATICS, APPLIED
MATHEMATICS

165
207

106
93

6

Acta Mechanica Sinica

力学学报(英文版)

0567-7718

447

0.583

ENGINEERING, MECHANICAL
MECHANICS

107
112

47
78

7

Acta Mechanica Solida Sinica

固体力学学报(英文版)

0894-9166

198

0.438

MATERIALS SCIENCE, MULTIDISCIPLINARY;MECHANICS

189
112

144
90

8

Acta Metallurgica Sinica

金属学报

0412-1961

928

0.449

METALLURGY & METALLURGICAL ENGINEERING

66

30

9

Acta Oceanologica Sinica

海洋学报(英文版)

0253-505X

494

0.716

OCEANOGRAPHY

50

36

10

Acta Pharmacologica Sinica

中国药理学报(英文版)

1671-4083

Pict 3166

1.677

CHEMISTRY, MULTIDISCIPLINARY
PHARMACOLOGY & PHARMACY 

127
205

40
129

11

Acta Physica Sinica

物理学报

1000-3290

Pict 6265

1.277

PHYSICS, MULTIDISCIPLINARY

69

30

12

Acta Physico-Chimica Sinica

物理化学学报

1000-6818

983

0.611

CHEMISTRY, PHYSICAL

110

94

13

Acta Phytotaxonomica Sinica

植物分类学报

0529-1526

351

0.31

PLANT SCIENCES

152

135

14

Acta Polymerica Sinica

高分子学报

1000-3304

764

0.541

POLYMER SCIENCE

74

58

15

Advances in Atmospheric Sciences

大气科学进展(英文版)

0256-1530

716

0.902

METEOROLOGY & ATMOSPHERIC SCIENCES

51

42

16

Algebra Colloquium

代数集刊(英文版)

1005-3867

135

0.237

MATHEMATICS, APPLIED
MATHEMATICS

165
207

155
191

17

Applied Mathematics and Mechanics

应用数学和力学(英文版) 

0253-4827

475

0.2

MATHEMATICS, APPLIED
MECHANICS

165
112

159
109

18

Asian Journal of Andrology

亚洲男科学杂志(英文版)

1008-682X

610

1.609

ANDROLOGY
UROLOGY & NEPHROLOGY 

5
55

3
33

19

Asian Journal of Control

亚洲控制学报(英文版)

1561-8625

238

0.437

AUTOMATION & CONTROL SYSTEMS

52

40

20

Biomedical and Environmental Sciences

生物医学与环境科学(英文版)

0895-3988

611

0.557

ENVIRONMENTAL SCIENCES
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 

160
100

140
94

21

Botanical Studies
(Changed from Botanical Bulletin of Academia Sinica)

植物学汇刊(英+中文版)

1817-406X

37

0.375

PLANT SCIENCES

152

127

22

Cell Research

细胞研究(英文版)

1001-0602

1579

4.217

CELL BIOLOGY

156

47

23

Chemical Journal of Chinese Universities-English Series

高等学校化学学报

0251-0790

2765

0.695

CHEMISTRY, MULTIDISCIPLINARY

127

84

24

Chemical Research in Chinese Universities

高等学校化学研究(英文版)

1005-9040

336

0.392

CHEMISTRY, MULTIDISCIPLINARY

127

104

25

China Ocean Engineering

中国海洋工程(英文版)

0890-5487

146

0.325

ENGINEERING, CIVIL
ENGINEERING, OCEAN
ENGINEERING, MECHANICAL
WATER RESOURCES  

88
15
107
59

64
7
73
54

26

Chinese Annals of Mathematic Series B

数学年刊(B辑,英文版)

0252-9599

278

0.354

MATHEMATICS

207

161

27

Chinese Chemical Letters

中国化学快报(英文版)

1001-8417

1055

0.336

CHEMISTRY, MULTIDISCIPLINARY

127

108

28

Chinese Journal of Analytical Chemistry

分析化学

0253-3820

1624

0.513

CHEMISTRY, ANALYTICAL

70

59

29

Chinese Journal of Catalysis

催化学报

0253-9837

700

0.596

CHEMISTRY, APPLIED
CHEMISTRY, PHYSICAL
ENGINEERING, CHEMICAL 

62
110
114

40
95
66

30

Chinese Journal of Chemical Engineering

中国化学工程学报(英文版)

1004-9541

406

0.462

ENGINEERING, CHEMICAL

1141

80

31

Chinese Journal of Chemical Physics

化学物理学报 (英文版)

1003-7713

375

0.469

PHYSICS, ATOMIC, MOLECULAR & CHEMICAL

32

30

32

Chinese Journal of Chemistry

中国化学(英文版)

1001-604X

1226

0.719

CHEMISTRY, MULTIDISCIPLINARY

127

83

33

Chinese Journal of Electronics

电子学报(英文版)

1022-4653

135

0.12

ENGINEERING, ELECTRICAL & ELECTRONIC

227

198

34

Chinese Journal of Geophysics-China Edition

地球物理学报

0001-5733

819

0.662

GEOCHEMISTRY & GEOPHYSICS

63

52

35

Chinese Journal of Inorganic Chemistry

无机化学学报

1001-4861

1097

0.569

CHEMISTRY, INORGANIC & NUCLEAR

43

38

36

Chinese Journal of Organic Chemistry

有机化学

0253-2786

1159

0.766

CHEMISTRY, ORGANIC

56

45

37

Chinese Journal of Physics

中国物理学刊(英文版)

0577-9073

240

0.165

PHYSICS, MULTIDISCIPLINARY

69

66

38

Chinese Journal of Physiology

中国生理学杂志(英文版)

0304-4920

264

0.803

PHYSIOLOGY

78

66

39

Chinese Journal of Polymer Science

高分子科学(英文版)

0256-7679

393

0.753

POLYMER SCIENCE

74

47

40

Chinese Journal of Structural Chemistry

结构化学(中+英文版)

0254-5861

923

0.696

CHEMISTRY, INORGANIC & NUCLEAR
CRYSTALLOGRAPHY

43
25

33
19

41

Chinese Journalof Astronomy and Astrophysics

中国天文和天体物理学报(英文版)

1009-9271

590

0.652

ASTRONOMY & ASTROPHYSICS

48

38

42

Chinese Medical Journal

中华医学杂志(英文版)

0366-6999

2315

0.636

MEDICINE, GENERAL & INTERNAL

100

73

43

Chinese Physics

中国物理(英文版)

1009-1963

3765

2.103

PHYSICS, MULTIDISCIPLINARY

69

16

44

Chinese Physics Letters

中国物理快报(英文版)

0256-307X

3362

0.812

PHYSICS, MULTIDISCIPLINARY

69

44

45

Chinese Science Bulletin

科学通报(英文版)

1001-6538

4256

0.77

MULTIDISCIPLINARY SCIENCES

50

21

46

Communications in Computational Physics

计算物理通讯(英文版)

1814-2406

150

1.633

PHYSICS, MATHEMATICAL

43

17

47

Communications in Theoretical Physics

理论物理通讯(英文版)

0253-6102

1421

0.676

PHYSICS, MULTIDISCIPLINARY

69

47

48

Episodes

地质幕(英文版)

0705-3797

741

0.868

GEOSCIENCES, MULTIDISCIPLINARY

137

88

49

Fungal Diversity

真菌多样性(英文版)

1560-2745

640

3.593

MYCOLOGY

19

2

50

High Energy Physics and Nuclear Physics

高能物理与核物理(英文版)

0254-3052

343

0.171

PHYSICS, NUCLEAR
PHYSICS, PARTICLES & FIELDS 

21
24

20
24

51

Insect Science

昆虫科学(英文版)

1672-9609

92

0.739

ENTOMOLOGY

73

37

52

Journal of Asian Natural Products Research

亚洲天然产物研究杂志(英文版)

1028-6020

322

0.612

PLANT SCIENCES
CHEMISTRY, APPLIED
CHEMISTRY, MEDICINAL
PHARMACOLOGY & PHARMACY 

152
62
41
205

108
39
37
190

53

Journal of Biomedical Science

生医科学杂志(英文版)

1021-7770

1379

2.024

MEDICINE, RESEARCH & EXPERIMENTAL

81

36

54

Journal of Central South University of Technology

中南工业大学学报(英文版)

1005-9784

261

0.189

METALLURGY & METALLURGICAL ENGINEERING

66

54

55

Journal of Computational Mathematics

计算数学(英文版)

0254-9409

355

0.667

MATHEMATICS, APPLIED
MATHEMATICS

165
207

89
65

56

Journal of Computer Science and Technology    

计算机科学技术学报(英文版)

1000-9000

284

0.441

COMPUTER SCIENCE, HARDWARE & ARCHITECTURE
COMPUTER SCIENCE, SOFTWARE ENGINEERING 

45
84

33
68

57

Journal of Environmental Science

环境科学学报(英文版)

1001-0742

600

0.48

ENVIRONMENTAL SCIENCES

160

142

58

Journal of Food and Drug Analysis

药物食品分析

1021-9498

285

0.568

FOOD SCIENCE & TECHNOLOGY
PHARMACOLOGY & PHARMACY 

103
205

71
192

59

Journal of Genetics and Genomics

遗传学报(英文版)

1673-8527

4

 

BIOCHEMISTRY & MOLECULAR BIOLOGY
GENETICS & HEREDITY 

263
132

263
132

60

Journal of Information and Engineering

信息科学与工程学刊(英文版)

1016-2364

171

0.202

COMPUTER SCIENCE, INFORMATION SYSTEMS

92

89

61

Journal of Infrared and Millimeter Waves

红外与毫米波学报

1001-9014

322

0.743

OPTICS

64

36

62

Journal of Inorganic Materials

无机材料学报

1000-324X

770

0.498

MATERIALS SCIENCE, CERAMICS

25

10

63

Journal of Integrative Plant Biology
(Changed from Acta Botanica Sinica since 2005)

植物学报(英文版)

1672-9072

281

0.671

BIOCHEMISTRY & MOLECULAR BIOLOGY
PLANT SCIENCES 

263
152

248
104

64

Journal of Iron and Steel Research International

钢铁研究学报(英文版)

1006-706X

147

0.202

METALLURGY & METALLURGICAL ENGINEERING

66

52

65

Journal of Materials Science & Technology

材料科学技术(英文版)

1005-0302

669

0.468

MATERIALS SCIENCE, MULTIDISCIPLINARY
METALLURGY & METALLURGICAL ENGINEERING 

189
66

139
28

66

Journal of Mechanics

力学(英文版)

1727-7191

107

0.722

MECHANICS

112

64

67

Journal of Polymer Research

高分子研究学刊(英文版)

1022-9760

368

0.842

POLYMER SCIENCE

74

42

68

Journal of Rare Earth

稀土学报(英文版)

1002-0721

660

0.398

CHEMISTRY, APPLIED

62

49

69

Journal of the Chinese Chemical Society

中国化学会会志(英文版)

0009-4536

1101

0.643

CHEMISTRY, MULTIDISCIPLINARY

127

90

70

Journal of the Chinese Institute of Chemical Engineers

中国化学工程学会会志(英文版)

0368-1653

216

0.431

ENGINEERING, CHEMICAL

114

84

71

Journal of the Chinese Institute of Engineer

中国工程学刊(英文版)

0253-3839

194

0.183

ENGINEERING, MULTIDISCIPLINARY

67

60

72

Journal of the Formosan Medical Association

台湾医志(英文版)

0929-6646

1166

0.5

MEDICINE, GENERAL & INTERNAL

100

79

73

Journal of University of Science and Technology Beijing

北京科技大学学报(英文版)

1005-8850

330

0.342

MATERIALS SCIENCE, MULTIDISCIPLINARY
METALLURGY & METALLURGICAL ENGINEERING
MINING & MINERAL PROCESSING   

189
66
16

154
43
9

74

Journal of Wuhan University of Technology
(Material Science Edition)

武汉理工大学学报(材料科学,英文版)

1000-2413

320

0.312

MATERIALS SCIENCE, MULTIDISCIPLINARY

189

158

75

Materials Chemistry and Physics
(Changed from Materials Chemistry)

材料物理化学(英法德文版)   

0254-0584

7175

1.871

MATERIALS SCIENCE, MULTIDISCIPLINARY

189

42

76

Plasma Science & Technology

等离子体科学与技术(英文版)

1009-0630

208

0.317

PHYSICS, FLUIDS & PLASMAS

25

24

77

Progress in Biochemistry and Biophysics

生物化学与生物物理进展

1000-3282

266

0.214

BIOCHEMISTRY & MOLECULAR BIOLOGY
BIOPHYSICS

263
69

259
65

78

Progress in Chemistry

化学进展

1005-281X

392

0.528

CHEMISTRY, MULTIDISCIPLINARY

127

96

79

Progress in Natural Science

自然科学进展(英文版)

Pict Pict 1002-0071

778

0.508

MULTIDISCIPLINARY SCIENCES

50

29

80

Rare Metal Materials and Engineering

稀有金属材料与工程

1002-185X

1087

0.286

MATERIALS SCIENCE, MULTIDISCIPLINARY
METALLURGY & METALLURGICAL ENGINEERING 

189
66

162
45

81

Rare Metals

稀有金属(英文版)

1001-0521

244

0.204

MATERIALS SCIENCE, MULTIDISCIPLINARY
METALLURGY & METALLURGICAL ENGINEERING 

189
66

169
51

82

Science in China Series A-Mathematics

中国科学(A辑 数学,英文版)

1006-9283

920

0.371

MATHEMATICS, APPLIED
MATHEMATICS

165
207

140
152

83

Science in China Series B-Chemistry

中国科学(B辑 化学,英文版)

1006-9291

881

0.615

CHEMISTRY, MULTIDISCIPLINARY

127

91

84

Science in China Series C-Life Sciences

中国科学(C辑 生命科学,英文版)

1006-9305

414

0.635

BIOLOGY

70

50

85

Science in China Series D-Earth Sciences

中国科学(D辑 地球科学,英文版)

1006-9313

1487

0.718

GEOSCIENCES, MULTIDISCIPLINARY

137

103

86

Science in China Series E-Technological Sciences

中国科学(E辑 技术科学,英文版)

1006-9321

334

0.265

ENGINEERING, MULTIDISCIPLINARY
MATERIALS SCIENCE, MULTIDISCIPLINARY 

67
189

56
165

87

Science in China Series F-Information Sciences

中国科学(F辑 信息科学,英文版)

1009-2757

139

0.437

COMPUTER SCIENCE, INFORMATION SYSTEMS

92

73

88

Science in China Series G-
Physics Mechanics & Astronomy

中国科学
(G辑 物理、数学、天文,英文版)

1672-1799

Pict 137

0.591

PHYSICS, MULTIDISCIPLINARY

69

54

89

Spectroscopy and Spectral Analysis

光谱学与光谱分析

1000-0593

2356

0.843

SPECTROSCOPY

39

28

90

Statistica Sinica

中华统计学志(英文版)

1017-0405

1198

0.603

STATISTICS & PROBABILITY

91

58

91

Taiwanese Journal of Mathematics

台湾数学期刊(英文版)

1027-5487

260

0.444

MATHEMATICS

207

128

92

Terrestrial Atmospheric and Oceanic Sciences

地球科学集刊(英文版)

1017-0839

446

0.407

GEOSCIENCES, MULTIDISCIPLINARY
METEOROLOGY & ATMOSPHERIC SCIENCES
OCEANOGRAPHY 

137
51
50

129
51
44

93

Transactin of Nonferrous Metals Society of China

中国有色金属学会会刊(英文版)

1003-6326

893

0.264

METALLURGY & METALLURGICAL ENGINEERING

66

48

94

Transportmetrica

交通方法论(英文版)

1812-8602

27

0.96

TRANSPORTATION SCIENCE & TECHNOLOGY

22

9

95

Zoological Studies

动物研究学刊(英文版)

1021-5506

479

0.731

ZOOLOGY

124

85

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2012-04-01 jackllzk

    是哦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2012-04-01 jackllzk

    是哦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2012-02-12 rasakiibrahim

    That takes us up to the next level. Great potisng.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2011-12-01 shangxin33

    hao

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2011-08-26 06chjr1983

    国内SCI不比国外好投,而且审稿周期偏长。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2011-08-16 fuqiang429

    好东东,不过 医学类

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2011-01-15 dumkzfpgqu

    links/go.txt;25;25

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2009-12-31 name

    comment1,

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2009-09-15 tybqmmimen

    dors-andrey-viagra1.txt;2;3

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=4156, encodeId=55364156f1, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4157, encodeId=73d2415eab, content=是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef559572, createdName=jackllzk, createdTime=Sun Apr 01 18:17:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3988, encodeId=5860398816, content=That takes us up to the next level. Great potisng., beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=rasakiibrahim, createdTime=Sun Feb 12 17:27:00 CST 2012, time=2012-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=3765, encodeId=87633e65be, content=hao, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=404251347, createdName=shangxin33, createdTime=Thu Dec 01 19:46:00 CST 2011, time=2011-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2868, encodeId=4f162868d3, content=国内SCI不比国外好投,而且审稿周期偏长。, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ace844671, createdName=06chjr1983, createdTime=Fri Aug 26 15:58:00 CST 2011, time=2011-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2780, encodeId=0f252e8043, content=好东东,不过 医学类, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e54b43986, createdName=fuqiang429, createdTime=Tue Aug 16 22:58:00 CST 2011, time=2011-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1965, encodeId=726c1965cd, content=links/go.txt;25;25, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dumkzfpgqu, createdTime=Sat Jan 15 07:39:00 CST 2011, time=2011-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907, encodeId=d2dc90e0e, content=comment1,, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=name, createdTime=Thu Dec 31 01:39:00 CST 2009, time=2009-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601, encodeId=cbcc60119, content=dors-andrey-viagra1.txt;2;3, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tybqmmimen, createdTime=Tue Sep 15 11:45:00 CST 2009, time=2009-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600, encodeId=b432600cb, content=dors-andrey-viagra1.txt;3;10, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pwwasnvcbgc, createdTime=Tue Sep 15 08:09:00 CST 2009, time=2009-09-15, status=1, ipAttribution=)]
    2009-09-15 pwwasnvcbgc

    dors-andrey-viagra1.txt;3;10

    0

相关资讯

如何向SCI源期刊投稿

摘 要:简要介绍SCI、网上获取SCI水资源、农业工程、环境科学、电、电子、环境工程和环境科学源期刊路径、投稿注意事项。 关键词:SCI;投稿;期刊 SCI是自然科学领域最为重要的检索和评价工具,它的来源期刊大都是国际性重要期刊。在SCI源期刊上发表研究论文已经成为许多科学研究工作者